WHO Collaborating Centre for International Drug Monitoring
(The Uppsala Monitoring Centre)
The Uppsala Monitoring Centre (UMC) was the first WHO Collaborating Centre to be established for pharmacovigilance when, in 1978, the scientific and technical responsibility of the WHO Programme for International Drug Monitoring was transferred to Sweden.
- The Centre is an independent, self-funded, non-profit organisation.
- The UMC holds and maintains the largest global database of Individual Case Safety Reports (ICSRs), known as VigiBaseTM, on behalf of WHO and its Member States.
- The UMC provides technical support and guidance to national centres in pharmacovigilance practice.
- The UMC develops and supports countries with reporting and data management tools such as VigiFlow, a web-based system that integrates international standards to record and manage ICSRs at many national centres.
- The UMC conducts training sessions and publishes scientific articles, books, newsletters and periodicals in pharmacovigilance and risk communication.